Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones

被引:212
作者
McKee, EE
Ferguson, M
Bentley, AT
Marks, TA
机构
[1] Indiana Univ, Sch Med, South Bend, IN 46617 USA
[2] Pharmacia Corp, Kalamazoo, MI 49001 USA
关键词
D O I
10.1128/AAC.01411-05
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The effects of a variety of oxazolidinones, with different antibacterial potencies, including linezolid, on mitochondrial protein synthesis were determined in intact mitochondria isolated from rat heart and liver and rabbit heart and bone marrow. The results demonstrate that a general feature of the oxazolidinone class of antibiotics is the inhibition of mammalian mitochondrial protein synthesis. Inhibition was similar in mitochondria from all tissues studied. Further, oxazolidinones that were very potent as antibiotics were uniformly potent in inhibiting mitochondrial protein synthesis. These results were compared to the inhibitory profiles of other antibiotics that function by inhibiting bacterial protein synthesis. Of these, chloramphenicol and tetracycline were significant inhibitors of mammalian mitochondrial protein synthesis while the macrolides, lincosamides, and aminoglycosides were not. Development of future antibiotics from the oxazolidinone class will have to evaluate potential mitochondrial toxicity.
引用
收藏
页码:2042 / 2049
页数:8
相关论文
共 40 条
[1]   MITOCHONDRIAL METABOLISM IN NORMAL, MYELOID, AND ERYTHROID HYPERPLASTIC RABBIT BONE-MARROW - EFFECT OF CHLORAMPHENICOL [J].
ABOUKHALIL, S ;
SALEM, Z ;
YUNIS, AA .
AMERICAN JOURNAL OF HEMATOLOGY, 1980, 8 (01) :71-79
[2]   Oxazolidinone antibiotics target the P site on Escherichia coli ribosomes [J].
Aoki, H ;
Ke, LZ ;
Poppe, SM ;
Poel, TJ ;
Weaver, EA ;
Gadwood, RC ;
Thomas, RC ;
Shinabarger, DL ;
Ganoza, MC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (04) :1080-1085
[3]   Linezolid-induced lactic acidosis. [J].
Apodaca, AA ;
Rakita, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (01) :86-87
[4]  
APPELGREN LE, 1982, ACTA PHARMACOL TOX, V51, P345
[5]   Oxazolidinone structure-activity relationships leading to linezolid [J].
Barbachyn, MR ;
Ford, CW .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (18) :2010-2023
[6]   Identification of phenylisoxazolines as novel and viable antibacterial agents active against gram-positive pathogens [J].
Barbachyn, MR ;
Cleek, GJ ;
Dolak, LA ;
Garmon, SA ;
Morris, J ;
Seest, EP ;
Thomas, RC ;
Toops, DS ;
Watt, W ;
Wishka, DG ;
Ford, CW ;
Zurenko, GE ;
Hamel, JC ;
Schaadt, RD ;
Stapert, D ;
Yagi, BH ;
Adams, WJ ;
Friis, JM ;
Slatter, JG ;
Sams, JP ;
Oien, NL ;
Zaya, MJ ;
Wienkers, LC ;
Wynalda, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (02) :284-302
[7]   Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity [J].
Barbachyn, MR ;
Hutchinson, DK ;
Brickner, SJ ;
Cynamon, MH ;
Kilburn, JO ;
Klemens, SP ;
Glickman, SE ;
Grega, KC ;
Hendges, SK ;
Toops, DS ;
Ford, CW ;
Zurenko, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :680-685
[8]   Structural basis for selectivity and toxicity of ribosomal antibiotics [J].
Böttger, EC ;
Springer, B ;
Prammananan, T ;
Kidan, Y ;
Sander, P .
EMBO REPORTS, 2001, 2 (04) :318-323
[9]   Peripheral neuropathy associated with prolonged use of linezolid [J].
Bressler, AM ;
Zimmer, SM ;
Gilmore, JL ;
Somani, J .
LANCET INFECTIOUS DISEASES, 2004, 4 (08) :528-531
[10]   Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections [J].
Brickner, SJ ;
Hutchinson, DK ;
Barbachyn, MR ;
Manninen, PR ;
Ulanowicz, DA ;
Garmon, SA ;
Grega, KC ;
Hendges, SK ;
Toops, DS ;
Ford, CW ;
Zurenko, GE .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :673-679